 | |
| Clinical data | |
|---|---|
| Other names | G3; Ganesha-3; GANESHA-3; 3C-G-3; 3,4-Trimethylene-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-3,4-(trimethylene)amphetamine; DOG-3 |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 8–12 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
G-3, also known as3,4-trimethylene-2,5-dimethoxyamphetamine, is apsychedelic drug of thephenethylamine,amphetamine, andDOx families.[1][2][3] It is one of severalhomologues ofGanesha (G).[1][2][3]
In his bookPiHKAL (Phenethylamines I Have Known and Loved) and other publications,Alexander Shulgin lists G-3's dose as 12 to 18 mgorally and itsduration as 8 to 12 hours.[1][2][3] The effects of G-3 were reported to includeclosed-eyeimagery, novisuals,fantasy, warmth, mellowness, nobody disturbance to hints of body discomfort, and "some suggestions of neurological sensitivity".[1]Music was described as not that exciting and it was felt that there could be easyeroticism but there was no push for it.[1] The drug was rated a "plus-three" on theShulgin Rating Scale despite there "not [being] much of anything" in one report.[1]
Thechemical synthesis of G-3 has been described.[1]
G-3 was first described in the literature by Shulgin inPiHKAL in 1991.[1] It is acontrolled substance inCanada under phenethylamine blanket-ban language.[4]
 | Thishallucinogen-related article is astub. You can help Wikipedia byadding missing information. |